Wells Fargo keeps Estee Lauder and Clorox at Equal-Weight, lifts both price targets
Wells Fargo kept Equal-Weight ratings on Estee Lauder and Clorox and raised their price targets to $110 and $90, per TradingView citing Benzinga data.
- published on Newsmetry
- original source published
the same feed is available to bots and dashboards through the api. connect the api →
what happened
Wells Fargo left Estee Lauder Cos and Clorox at Equal-Weight on November 3, 2026, while raising its Estee Lauder target to $110 from $95, a 15.8% increase. The new target implies about 5.0% upside from the November 2 close of $104.77.
For Clorox, the bank lifted its target to $90 from $85, a 5.9% rise, which is roughly in line with the November 2 close of $89.90. Over the past 30 days, the five latest analyst notes on Estee Lauder carried targets between $109 and $126, according to Benzinga data shown by TradingView.
why it matters
Both stocks keep a neutral rating, so the change lies in the price targets rather than the recommendation. Updates like this are routine and usually have limited impact on the broader market.
tags
instruments
sources
- Wells Fargo maintains Estee Lauder Cos at Equal-Weight, raises price target to $110 from $95 — TradingView, 3 November 2026 at 15:13 UTC
- Wells Fargo maintains Clorox at Equal-Weight, raises price target to $90 from $85 — TradingView, 3 November 2026 at 15:10 UTC
- Wells Fargo maintains Olin at Equal-Weight, raises price target to $17 from $16 — TradingView, 3 November 2026 at 15:30 UTC
prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.
alerts on your topics, the morning digest and the api — in your account.
get stories in real time ↗